A0A2R8Z7Y7 (A0A2R8Z7Y7_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)

Baculoviral IAP repeat containing 2 UniProtKBInterProSTRINGInteractive Modelling

618 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q13490

Available Structures

28 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The BIR3 domain of cIAP1 in complex with the N terminal peptide from SMAC/DIABLO (AVPIAQ). Heteromer
Q13490; Q9NR28;
260-351
100ZN;
Ternary complex structure - BTK cIAP compound 15 Heteromer
Q06187; Q13490;
260-351
100ZN;TKY;
Ternary complex structure - BTK cIAP compound 17 Heteromer
Q06187; Q13490;
260-350
100TL7;ZN;
Structure of cIAP1, BTK and BCCov Heteromer
Q06187; Q13490;
261-351
100TOO;ZN;
CIAP1-BIR3 in complex with N-terminal peptide from Caspase-9 (ATPFQE) Heteromer
P55211; Q13490;
263-352
100ZN;
Crystal structure of human BIRC2 BIR3 domain in complex with histone H3 Heteromer
Q13490; Q6NXT2;
261-346
100EDO;ZN;
Crystal structure of cIAP1 RING domain bound to UbcH5B-Ub and a non-covalent Ub Heteromer
P0CG47; P62837; Q13490;
556-618
100ZN;
cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac037homo-4-mer260-362
100SMK;ZN;
cIAP1-BIR3 in complex with a divalent Smac mimetichomo-2-mer260-362
100ZN;0O6;
IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerizationmonomer265-616
98.98ZN;
Structure of cIAP1 CARDmonomer435-562
100
cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac066monomer259-361
100ZN;BMB;
Structure of cIAP1-BIR3 and inhibitormonomer260-357
100ZN;436;PO4;
Crystal structure of cIAP1-BIR3 in complex with a covalently bound SMmonomer260-357
100ZN;C3K;
SOLUTION STRUCTURE OF A BACULOVIRAL INHIBITOR OF APOPTOSIS (IAP) REPEATmonomer266-363
100ZN;
Small Molecule inhibitors of IAPmonomer266-362
100ZN;SO4;7H9;
Crystal structure of cIAP1 BIR3 bound to T3256336monomer260-352
100ZN;1AQ;
Crystal structure of cIAP1 BIR3 bound to T3258042monomer260-352
100ZN;2DX;
Crystal structure of cIAP1 BIR3 bound to T3170284monomer261-352
100ZN;1BG;
Structure of cIAP1 with BCCovmonomer260-351
100ZN;TO0;
Crystal structure of clAP1 BIR3 bound to T3261256monomer261-352
100ZN;1Y0;
Crystal structure of cIAP1 BIR3 bound to T3450325monomer263-352
100ZN;2DY;
Crystal structure of clAP1 BIR3 bound to T3226692monomer263-352
100ZN;1YH;
Structure of cIAP with compound 15monomer266-352
100ZN;TKY;
Crystal structure of human BIRC2 BIR3 domain in complex with inhibitor LCL-161monomer261-345
100ZN;EDO;IUN;
Apo structure of BIR2 Domain of BIRC2monomer175-252
100ZN;EDO;
Structure of BIR1 from cIAP1monomer41-118
100ZN;
Crystal structure of cIAP1 BIR3 bound to GDC0152monomer267-343
96.92ZN;

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3t6p.1.Amonomer0.83265-616
ZN;98.55
2l9m.1.Amonomer0.66435-561
100.00
8fvu.1.Amonomer0.5240-254
ZN;33.33
8fml.1.Amonomer0.5195-349
28.90